Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00942331
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:31.458043+00:00
Published At
2020-02-17T00:00:00+00:00
Record Updated At
2023-10-16
Results Posted At
2020-02-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Urothelial Carcinoma", "Metastatic Bladder Urothelial Carcinoma", "Metastatic Prostate Carcinoma", "Metastatic Renal Pelvis Urothelial Carcinoma", "Metastatic Ureter Urothelial Carcinoma", "Metastatic Urethral Urothelial Carcinoma", "Metastatic Urothelial Carcinoma", "Stage IV Bladder Urothelial Carcinoma AJCC v7", "Stage IV Prostate Cancer AJCC v7", "Stage IV Renal Pelvis Cancer AJCC v7", "Stage IV Ureter Cancer AJCC v7", "Stage IV Urethral Cancer AJCC v7", "Unresectable Urothelial Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-16"
protocolSection.identificationModule.nctId
"NCT00942331"
protocolSection.identificationModule.officialTitle
"A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-02-17"

Study condition terms

  • Advanced Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Bladder Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Prostate Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Renal Pelvis Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Ureter Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Urethral Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Bladder Urothelial Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Renal Pelvis Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Ureter Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Urethral Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Unresectable Urothelial Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.